cetylpyridinium chloride anhydrous has been researched along with Cytomegalic Inclusion Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Egbuonu, L | 1 |
| Sinclair, J; Sissons, P; Taylor-Wiedeman, J | 1 |
1 review(s) available for cetylpyridinium chloride anhydrous and Cytomegalic Inclusion Disease
| Article | Year |
|---|---|
Child health and social status.
Topics: Anemia, Hypochromic; Asthma; Child; Cytomegalovirus Infections; Health; Health Status; Hearing Disorders; Hospitalization; Humans; Infant, Newborn; Infant, Premature; Lead Poisoning; Mental Disorders; Mortality; Otitis Media; Social Class; United States; Vision Disorders | 1982 |
1 other study(ies) available for cetylpyridinium chloride anhydrous and Cytomegalic Inclusion Disease
| Article | Year |
|---|---|
Induction of endogenous human cytomegalovirus gene expression after differentiation of monocytes from healthy carriers.
Topics: Adult; Antigens, Viral; Base Sequence; Carrier State; Cell Differentiation; Cells, Cultured; Cytomegalovirus; Cytomegalovirus Infections; Gene Expression Regulation, Viral; Granulocyte-Macrophage Colony-Stimulating Factor; Health; Humans; Immediate-Early Proteins; Macrophages; Molecular Sequence Data; Monocytes; Polymerase Chain Reaction; Tetradecanoylphorbol Acetate; Transcription, Genetic; Transcriptional Activation | 1994 |